ChengDa Pharmaceuticals Co. Ltd. (301201) — Financial Flexibility Index
ChengDa Pharmaceuticals Co. Ltd. (301201) has a Financial Flexibility Index of 1.08x as of December 2024. Free cash flow of CN¥315.01 Million (operating CF CN¥28.65 Million minus capex CN¥286.36 Million) represents 1% of total liabilities (CN¥290.77 Million). Also explore ChengDa Pharmaceuticals Co. Ltd. net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ChengDa Pharmaceuticals Co. Ltd. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for ChengDa Pharmaceuticals Co. Ltd. across 6 annual periods. Check 301201 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for ChengDa Pharmaceuticals Co. Ltd. (2019–2024)
Year-by-year free cash flow to debt coverage for ChengDa Pharmaceuticals Co. Ltd.. For the full company profile including market capitalisation, see 301201 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.08x | CN¥315.01 Million | CN¥28.65 Million | CN¥290.77 Million | ▼ -54.1% |
| 2023 | 2.36x | CN¥416.74 Million | CN¥192.07 Million | CN¥176.40 Million | ▼ -1.3% |
| 2022 | 2.39x | CN¥253.36 Million | CN¥47.67 Million | CN¥105.81 Million | ▲ +65.5% |
| 2021 | 1.45x | CN¥221.84 Million | CN¥83.14 Million | CN¥153.30 Million | ▼ -43.5% |
| 2020 | 2.56x | CN¥192.78 Million | CN¥128.97 Million | CN¥75.30 Million | ▲ +308.5% |
| 2019 | 0.63x | CN¥118.59 Million | CN¥67.52 Million | CN¥189.21 Million | — |